Glucotrack, Inc.

Contributing Author

Recent Articles by Glucotrack, Inc.

Jul-08	Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform GlobeNewswire
May-26	Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions GlobeNewswire
May-14	Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights GlobeNewswire
May-07	Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology GlobeNewswire
Apr-30	Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology GlobeNewswire
Apr-21	Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology GlobeNewswire
Mar-30	Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights GlobeNewswire
Mar-27	Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones GlobeNewswire
Mar-10	Glucotrack to Present at LSI USA '26 Medtech Innovation Summit GlobeNewswire
Jan-29	Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform GlobeNewswire
Dec-30	Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor GlobeNewswire
Nov-13	Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights GlobeNewswire
Nov-03	Glucotrack, Inc. Encourages Shareholders to Vote GlobeNewswire
Oct-29	Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team GlobeNewswire
Oct-28	Glucotrack, Inc. Reminds Shareholders to Vote GlobeNewswire
Sep-11	Glucotrack to Participate in the Q3 Virtual Investor Summit GlobeNewswire
Aug-14	Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire
Aug-06	Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology GlobeNewswire
Jul-31	Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting GlobeNewswire
Jul-08	Glucotrack Announces Repurchase of Series A Warrants GlobeNewswire
Jun-25	Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions GlobeNewswire
Jun-12	Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements GlobeNewswire
Jun-04	Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions GlobeNewswire
May-28	Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD GlobeNewswire
May-20	Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development GlobeNewswire
May-14	Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire
May-13	Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor GlobeNewswire

Glucotrack, Inc.

Recent Articles by Glucotrack, Inc.

Upgrade your Finviz experience